| Code | CSB-RA009443MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to reference antibody ALMB-0168, targeting GJA1 (Gap Junction Alpha-1), also known as Connexin 43 (Cx43). GJA1 encodes the most widely expressed gap junction protein in mammalian tissues, forming intercellular channels that enable direct cell-to-cell communication through the passage of ions, metabolites, and secondary messengers. This protein plays critical roles in cardiac conduction, bone development, wound healing, and cellular differentiation. Dysregulation of GJA1 has been implicated in various pathological conditions including cardiac arrhythmias, oculodentodigital dysplasia (ODDD), inflammatory responses, and cancer progression, where altered gap junction communication affects tumor growth and metastasis.
As a biosimilar to ALMB-0168, this antibody provides researchers with a reliable tool for investigating GJA1 expression patterns, localization, and function across diverse biological systems. It supports studies examining gap junction dynamics, intercellular communication mechanisms, and the role of connexin proteins in normal physiology and disease states. This antibody is valuable for advancing understanding of cell-cell communication pathways and their therapeutic potential.
There are currently no reviews for this product.